Baxter International, Inc.
Baxter is a global diversified healthcare company that develops products and therapies to make a meaningful difference in the lives of people with hemophilia, kidney disease, immune disorders and other chronic and acute conditions.
The company operates in three segments: BioScience develops plasma-based and recombinant proteins; other biopharmaceutical products, including plasma-based therapies, biosurgery products and vaccines; and technologies used in adult stem cell therapies. Medication Delivery provides intravenous solutions and specialty products used for fluid replenishment, anesthesia, nutrition, pain management, antibiotic therapy and chemotherapy. Renal develops products and services to treat end-stage kidney disease.
Baxter’s heritage has been built on more than 75 years of innovation in healthcare, including a long history of firsts.
- First commercially manufactured IV solutions.
- First commercial artificial kidney.
- First "needleless" IV access system.
- First concentrated clotting factor for hemophilia.
- First portable dialysis therapy.
| While Baxter’s roots are in Glenview and its corporate headquarters are in Deerfield, today it is truly an international company with a strong global brand and broad geographic reach. |
Baxter products are manufactured in 26 countries and sold in more than 100 countries. More than half of Baxter’s earnings come from outside the U.S., and more than 70 percent of its sales are in businesses in which it is the leader in the global markets in which it participates.
